NCT00216619 – A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention Posted on November 22, 2017 by tsuperadmin -
NCT00113815 – A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy for Infants (1-24 Months of Age) With Refractory Partial-Onset Seizures Posted on October 12, 2016 by tsuperadmin -
A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children Posted on May 26, 2016 by tsuperadmin -
NCT00210912 – A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00212810 – TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study Posted on November 10, 2014 by tsuperadmin -
NCT00216606 – A Randomized Double-Blind Placebo Controlled Trial to Investigate the Efficacy and Tolerability of Topiramate in the Prophylaxis of Chronic Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00236561 – A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00231595 – A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00236509 – A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine Posted on November 10, 2014 by tsuperadmin -
NCT00210860 – An Open-label Study of the Safety and Efficacy of Topiramate for Migraine Prophylaxis: Extension Study to CAPSS-277 Posted on September 25, 2014 by tsuperadmin -
The YODA Project